Ophthalmological lore in the Corpus Hippocraticum

Lascaratos, John; Marketos, Spiros

doi:10.1007/978-94-009-1307-3_5

Cited by 3 publications

(3 citation statements)

References 1 publication

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Hippocrates's works are gathered in a collection named Corpus Hippocraticus which includes treatises written by him as well as his students (5). Corpus Hippocraticus discusses mental illness (1) and various medical specialties, such as anatomy (1), general pathology (1), gynecology and obstetrics (1), surgery (1, 2, 8), otorhinolaryngology (1), ophthalmology (9), and cardiology (4, 7).…”

Section: Medicine In Ancient Greece (1100–323 Bce)mentioning

confidence: 99%

“…As for the discipline of ophthalmology, several eye diseases and symptoms, such as pterygium, cellulites, ectropion, diseases of the cilia, prolapse of the iris, amaurosis, amblyopia, photopsia, and nystagmus, can be found in the Corpus Hippocraticus (9). Hippocrates contributed to the management of facial injuries-his treatise "Joints" contains information about diseases of the oral cavity, mandibular dislocation and fractures, depressed and deviated nasal fractures, and ear injuries (6).…”

Section: Characteristics Of Hippocratic Medicine and Contributions Tomentioning

confidence: 99%

See 1 more Smart Citation

Science in Greece: from the age of Hippocrates to the age of the genome

et al. 2006

View full text Add to dashboard Cite

Section: Medicine In Ancient Greece (1100–323 Bce)mentioning

confidence: 99%

Section: Characteristics Of Hippocratic Medicine and Contributions Tomentioning

confidence: 99%

Science in Greece: from the age of Hippocrates to the age of the genome

et al. 2006

View full text Add to dashboard Cite

“…In the Mediterranean area the "Corpus Hippocraticum" (a collection of 62 medical works written between the 5th century BCE and the 2nd century AD) that were ascribed to Hippocrates (460-377 BC), represents the early medical rational approach that looks to the disease as a natural phenomenon linked to the body and not to supernatural forces [4]. In the opinion of Hippocratic physicians, menstruation was regarded as crucial to the general health of women, and every anomaly was addressed through the administration of medicinal plants aimed at either promoting, inhibiting, or regulating the menstrual process [5].…”

Section: Introductionmentioning

confidence: 99%

Plants in Menstrual Diseases: A Systematic Study from Italian Folk Medicine on Current Approaches

Mazzei,

Genovese,

Magariello

et al. 2024

Plants

View full text Add to dashboard Cite

Background: Plant-based remedies have been used since antiquity to treat menstrual-related diseases (MD). From the late nineteenth to the early to mid-twentieth century, Italian folk remedies to treat “women’s diseases” were documented in a vast corpus of literature sources. Aim: The purpose of this paper is to bring to light the plant-based treatments utilized by Italian folk medicine to heal clinical manifestations of premenstrual syndrome (PMS), dysmenorrhea, amenorrhea and menstrual disorders in an attempt to discuss these remedies from a modern pharmacological point of view. Moreover, we compare the medical applications described by Hippocrates with those utilized by Italian folk medicine to check if they result from a sort of continuity of use by over two thousand years. Results: Out of the 54 plants employed in Italian folk medicine, 25 (46.3%) were already documented in the pharmacopoeia of the Corpus Hippocraticum for treating MD. Subsequently, a detailed search of scientific data banks such as Medline and Scopus was undertaken to uncover recent results concerning bioactivities of the plant extracts to treat MD. About 26% of the plants used by Italian folk medicine, nowadays, have undergone human trials to assess their actual efficacy. At the same time, about 41% of these herbal remedies come back to in different countries. Conclusions: Active principles extracted from plants used by Italian folk healers could be a promising source of knowledge and represent strength candidates for future drug discovery for the management of MD.

show abstract